Related Experiment Videos

CD30: expression and function in health and disease

R Horie1, T Watanabe

  • 1The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo, 108-3639, Japan.

Seminars in Immunology
|November 25, 1998
PubMed

Insights

CD30, a tumor necrosis factor receptor superfamily member, is expressed on lymphocytes and lymphoid neoplasms. Its ligand (CD30L) is found on various immune cells, suggesting a role in co-stimulatory immune signals.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Biology

Background:

  • CD30 is a marker for Hodgkin's lymphoma cells.
  • CD30 and CD30L belong to the TNF receptor and TNF superfamilies.
  • CD30 is expressed on specific lymphocytes and lymphoid neoplasms.

Purpose of the Study:

  • To characterize CD30 and CD30L.
  • To understand the expression patterns of CD30 and CD30L.
  • To elucidate the biological functions and signal transduction of CD30.

Main Methods:

  • Cloning and characterization of CD30 and CD30L cDNAs.
  • Analysis of CD30 and CD30L expression in various cell types.
  • Investigation of CD30 signal transduction pathways.

Main Results:

  • CD30 and CD30L were identified as members of the TNFR and TNF superfamilies.
  • Expression of CD30 is largely restricted to specific immune cells and lymphoid neoplasms.
  • CD30 signal transduction involves TNFR-associated factors (TRAFs).

Conclusions:

  • CD30 plays a role in immune regulation, particularly co-stimulation.
  • The diverse biological functions of CD30 are mediated through TRAF proteins.
  • Further research is needed to fully understand CD30 signaling mechanisms.

Related Concept Videos